IP Literature Watch: May 2025
We are pleased to present the latest edition of CRA’s IP Literature Watch. This issue contains pieces on antitrust & IP, licensing, litigation, innovation, law...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Empirical and theoretical approaches pioneered by CRA economists have been accepted as standard practice by competition economists and enforcers worldwide.
We tailor our analyses to fit the facts and economics of each case, bringing a unique combination of creativity and rigor to each matter. CRA economists have also testified in litigated competition cases, or met with and provided submissions to antitrust enforcement agencies. In our work, and in discussions with clients, we distill complex competition issues and economic analyses into concepts and arguments that are understandable to non-economists.
Our expertise in antitrust economics, econometrics, mergers, acquisitions, divestitures, and related matters has made us the firm of choice for clients and competition authorities around the globe. Our globally based antitrust economists have the knowledge, jurisdiction-specific expertise, and geographic presence required to efficiently support clients around the world.
We are pleased to present the latest edition of CRA’s IP Literature Watch. This issue contains pieces on antitrust & IP, licensing, litigation, innovation, law...
Svend Albaek and Raphaël De Coninck explore the proposed use of “dynamic capabilities” analysis in European merger control as authorities increasingly focus on...
CRA is a proud sponsor of the workshop focusing on innovation, industrial policy and economic growth Oli Latham is a panelist on “Competition Policy,...
Laurent Flochel is a speaker during the program. Topic 1: Litigation strategies & structural levers – Models for the consolidation of debts in French law –...
Elina Koustoumpardi is a panelist during the session titled “Hot Topics in Merger Control: Health Value Chain (Pharma, Healthcare), Sustainability, Innovation...
Dynamic competition is becoming an ever more important aspect of merger review processes worldwide. Agencies focus closely on how merging Parties think about...